Target General Information
Target ID T46263
Target Name Solute carrier family 3 member 2
Synonyms 4F2 cellsurface antigen heavy chain; 4F2 heavy chain antigen; 4F2hc; CD98; Lymphocyte activation antigen 4F2 large subunit; SLC3A2
Target Type Clinical Trial
Gene Name SLC3A2
Biochemical Class RBAT transport accessory protein
UniProt ID 4F2_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease Acute myelocytic leukemia
Example drug IGN523 Phase 1 [524608], [1572592]
Tissue Bone marrow
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: 0.56
Z-score: 1.14
P-value: 3.68E-17
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Reference
Ref 524608ClinicalTrials.gov (NCT02040506) A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML. U.S. National Institutes of Health.
Ref 1572592NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.